432 related articles for article (PubMed ID: 30759967)
1. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update.
Kim TH; Kim SY; Tang A; Lee JM
Clin Mol Hepatol; 2019 Sep; 25(3):245-263. PubMed ID: 30759967
[TBL] [Abstract][Full Text] [Related]
2. Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.
Jeon SK; Lee JM; Joo I; Yoo J; Park JY
Eur Radiol; 2020 Sep; 30(9):4762-4771. PubMed ID: 32333148
[TBL] [Abstract][Full Text] [Related]
3. Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines.
Kim TH; Yoon JH; Lee JM
Korean J Radiol; 2019 Jun; 20(6):863-879. PubMed ID: 31132813
[TBL] [Abstract][Full Text] [Related]
4. Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.
Lee S; Kim SS; Chang DR; Kim H; Kim MJ
Clin Mol Hepatol; 2020 Jul; 26(3):340-351. PubMed ID: 32492765
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.
Park SH; Shim YS; Kim B; Kim SY; Kim YS; Huh J; Park JH; Kim KW; Lee SS
Eur Radiol; 2021 Jul; 31(7):4751-4763. PubMed ID: 33389037
[TBL] [Abstract][Full Text] [Related]
6. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
Kang HJ; Lee JM; Yoon JH; Han JK
Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.
Byun J; Choi SH; Byun JH; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Hepatol Int; 2020 Jul; 14(4):534-543. PubMed ID: 32314171
[TBL] [Abstract][Full Text] [Related]
8. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC.
Erkan B; Meier J; Clark TJ; Kaplan J; Lambert JR; Chang S
PLoS One; 2019; 14(12):e0226291. PubMed ID: 31821360
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging.
Hwang SH; Park MS; Park S; Lim JS; Kim SU; Park YN
Eur Radiol; 2021 Jul; 31(7):4492-4503. PubMed ID: 33409787
[TBL] [Abstract][Full Text] [Related]
11. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues.
Yoon JH; Park JW; Lee JM
Korean J Radiol; 2016; 17(1):7-24. PubMed ID: 26798212
[TBL] [Abstract][Full Text] [Related]
13. ESR Essentials: diagnosis of hepatocellular carcinoma-practice recommendations by ESGAR.
Cannella R; Zins M; Brancatelli G
Eur Radiol; 2024 Apr; 34(4):2127-2139. PubMed ID: 38379018
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of LI-RADS v2018 versus KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging with Hepatobiliary Agent: A Systematic Review and Meta-Analysis of Comparative Studies.
Shin J; Lee S; Yoon JK; Son WJ; Roh YH; Chung YE; Choi JY; Park MS
Gut Liver; 2023 May; 17(3):466-474. PubMed ID: 36317516
[TBL] [Abstract][Full Text] [Related]
15. 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm.
Lee JM; Park JW; Choi BI
Dig Dis; 2014; 32(6):764-77. PubMed ID: 25376295
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.
Kim TK; Noh SY; Wilson SR; Kono Y; Piscaglia F; Jang HJ; Lyshchik A; Dietrich CF; Willmann JK; Vezeridis A; Sirlin CB
Clin Mol Hepatol; 2017 Dec; 23(4):280-289. PubMed ID: 28911220
[TBL] [Abstract][Full Text] [Related]
17. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma.
Bota S; Piscaglia F; Marinelli S; Pecorelli A; Terzi E; Bolondi L
Liver Cancer; 2012 Nov; 1(3-4):190-200. PubMed ID: 24159584
[TBL] [Abstract][Full Text] [Related]
18. Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.
Lee S; Kim MJ; Kim SS; Shin H; Kim DY; Choi JY; Park MS; Mitchell DG
Hepatol Int; 2020 Jan; 14(1):70-79. PubMed ID: 31802388
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.
Ronot M; Fouque O; Esvan M; Lebigot J; Aubé C; Vilgrain V
J Hepatol; 2018 Apr; 68(4):715-723. PubMed ID: 29274407
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]